BioNTech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 8:05 AM EDT
343.50quote price arrow down-15.68 (-4.37%)
Volume
83,683
Close
359.18quote price arrow down-13.47 (-3.61%)
Volume
5,492,946
52 week range
58.81 - 464.00
Loading...
  • Open370.74
  • Day High370.80
  • Day Low344.81
  • Prev Close359.18
  • 52 Week High464.00
  • 52 Week High Date08/10/21
  • 52 Week Low58.81
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap87.108B
  • Shares Out242.52M
  • 10 Day Average Volume3.49M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change340.6

KEY STATS

  • Open370.74
  • Day High370.80
  • Day Low344.81
  • Prev Close359.18
  • 52 Week High464.00
  • 52 Week High Date08/10/21
  • 52 Week Low58.81
  • 52 Week Low Date09/24/20
  • Market Cap87.108B
  • Shares Out242.52M
  • 10 Day Average Volume3.49M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change340.6

RATIOS/PROFITABILITY

  • EPS (TTM)19.38
  • P/E (TTM)18.53
  • Fwd P/E (NTM)8.35
  • EBITDA (MRQ)7.022B
  • ROE (MRQ)133.85%
  • Revenue (MRQ)9.14B
  • Gross Margin (MRQ)85.01%
  • Net Margin (MRQ)52.41%
  • Debt To Equity (MRQ)21.87%

EVENTS

  • Earnings Date11/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO8:2908:29
Dr. Fauci on boosters, breakthrough cases and CDC data

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
447.01-2.91-0.65%
REGN
Regeneron Pharmaceuticals Inc
651.88-1.30-0.20%
BIIB
Biogen Inc
300.19+0.50+0.17%
MRNA
Moderna Inc
430.05-10.60-2.41%
GRFS
Grifols SA
15.39+0.94+6.51%